Troy Edward Wilson - 02 Jan 2026 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Signature
Teresa Bair, Attorney-in-fact for Troy E. Wilson
Issuer symbol
KURA
Transactions as of
02 Jan 2026
Net transactions value
$0
Form type
4
Filing time
06 Jan 2026, 16:31:04 UTC
Previous filing
14 Nov 2025
Next filing
26 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WILSON TROY EDWARD President and CEO, Director C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO Teresa Bair, Attorney-in-fact for Troy E. Wilson 06 Jan 2026 0001589597

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +1,120,000 $0.000000 1,120,000 02 Jan 2026 Common Stock 1,120,000 $10.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in 48 equal monthly installments commencing on the grant date.